Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Shih, Yu Yin ^a,b   Lee, Hsinyu ^b   Nakagawara, Akira ^c   Juan, Hseuh Fen ^b   Jeng, Yung Ming ^d   Tsay, Yeou Guang ^e   Lin, Dong Tsamn ^d,f   Hsieh, Fon Jou ^g   Pan, Chien Yuan ^b   Hsu, Wen Ming ^d,f   Liao, Yung Feng ^a  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f Childhood Cancer Foundation   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 75; PROTEASOME; PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG; GLUCOSE REGULATED PROTEINS; GLUCOSE-REGULATED PROTEINS; HEAT SHOCK PROTEIN 70; MEMBRANE PROTEIN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL NUCLEUS; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; ANIMAL; CELL DIFFERENTIATION; DNA RESPONSIVE ELEMENT; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; DOWN-REGULATION; GENE DOSAGE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; NEUROBLASTOMA; NEURONS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TRETINOIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054095415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026236     Document Type: Article

References (53)

1. Maris JM, (2010) Recent advances in neuroblastoma. N Engl J Med 362: 2202-2211.
2. Wagner LM, Danks MK, (2009) New therapeutic targets for the treatment of high-risk neuroblastoma. J Cell Biochem 107: 46-57.
3. Sidell N, Altman A, Haussler MR, Seeger RC, (1983) Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 148: 21-30.
4. Brodeur GM, (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
5. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, et al. (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 27: 1007-1013.
6. Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, et al. (2009) Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer 52: 44-50.
7. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173.
8. Reynolds CP, Schindler PF, Jones DM, Gentile JL, Proffitt RT, et al. (1994) Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines. Prog Clin Biol Res 385: 237-244.
9. Maden M, (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8: 755-765.
10. Lefebvre P, Martin PJ, Flajollet S, Dedieu S, Billaut X, et al. (2005) Transcriptional activities of retinoic acid receptors. Vitam Horm 70: 199-264.
11. Bastien J, Rochette-Egly C, (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16.
12. McGrane MM, (2007) Vitamin A regulation of gene expression: molecular mechanism of a prototype gene. J Nutr Biochem 18: 497-508.
13. Niederreither K, Dolle P, (2008) Retinoic acid in development: towards an integrated view. Nat Rev Genet 9: 541-553.
14. Deocaris CC, Widodo N, Ishii T, Kaul SC, Wadhwa R, (2007) Functional significance of minor structural and expression changes in stress chaperone mortalin. Ann N Y Acad Sci 1119: 165-175.
15. Wadhwa R, Taira K, Kaul SC, (2002) An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones 7: 309-316.
16. Hsu WM, Lee H, Juan HF, Shih YY, Wang BJ, et al. (2008) Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Clin Cancer Res 14: 6237-6245.
17. Mark M, Ghyselinck NB, Chambon P, (2006) Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46: 451-480.
18. de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A, (1990) Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177-180.
19. Knutson DC, Clagett-Dame M, (2008) atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion. Arch Biochem Biophys 477: 163-174.
20. Suenaga Y, Kaneko Y, Matsumoto D, Hossain MS, Ozaki T, et al. (2009) Positive auto-regulation of MYCN in human neuroblastoma. Biochem Biophys Res Commun 390: 21-26.
21. Balmer JE, Blomhoff R, (2002) Gene expression regulation by retinoic acid. J Lipid Res 43: 1773-1808.
22. Merrill RA, Ahrens JM, Kaiser ME, Federhart KS, Poon VY, et al. (2004) All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biol Chem 385: 605-614.
23. Jeong H, Kim MS, Kim SW, Kim KS, Seol W, (2006) Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor. J Neurochem 98: 386-394.
24. Merrill RA, Plum LA, Kaiser ME, Clagett-Dame M, (2002) A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos. Proc Natl Acad Sci U S A 99: 3422-3427.
25. Craig EA, Kramer J, Shilling J, Werner-Washburne M, Holmes S, et al. (1989) SSC1, an essential member of the yeast HSP70 multigene family, encodes a mitochondrial protein. Mol Cell Biol 9: 3000-3008.
26. Kawai A, Nishikawa S, Hirata A, Endo T, (2001) Loss of the mitochondrial Hsp70 functions causes aggregation of mitochondria in yeast cells. J Cell Sci 114: 3565-3574.
27. Smith DF, Toft DO, (2008) Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 22: 2229-2240.
28. Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, et al. (2007) Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Cancer Res 67: 10455-10465.
29. Zhao HL, Ueki N, Marcelain K, Hayman MJ, (2009) The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway. Biochem Biophys Res Commun 383: 119-124.
30. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ, (2000) Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res 60: 2247-2252.
31. Almgren MA, Henriksson KC, Fujimoto J, Chang CL, (2004) Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res 2: 387-394.
32. Kaul SC, Taira K, Pereira-Smith OM, Wadhwa R, (2002) Mortalin: present and prospective. Exp Gerontol 37: 1157-1164.
33. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, et al. (1995) Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res 216: 101-106.
34. Wadhwa R, Sugihara T, Yoshida A, Nomura H, Reddel RR, et al. (2000) Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res 60: 6818-6821.
35. Peverali FA, Orioli D, Tonon L, Ciana P, Bunone G, et al. (1996) Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 12: 457-462.
36. Thiele CJ, Reynolds CP, Israel MA, (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313: 404-406.
37. Gabriele N, Pontoriero GF, Thomas N, Shethwala SK, Pristupa ZB, et al. (2010) Knockdown of mortalin within the medial prefrontal cortex impairs normal sensorimotor gating. Synapse 64: 808-813.
38. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, et al. (1994) Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367: 480-483.
39. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, et al. (1994) Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367: 476-480.
40. Michalak M, Burns K, Andrin C, Mesaeli N, Jass GH, et al. (1996) Endoplasmic reticulum form of calreticulin modulates glucocorticoid-sensitive gene expression. J Biol Chem 271: 29436-29445.
41. Rochette-Egly C, (2003) Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 15: 355-366.
42. Keriel A, Stary A, Sarasin A, Rochette-Egly C, Egly JM, (2002) XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell 109: 125-135.
43. Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C, (2002) Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J 21: 3760-3769.
44. Desai D, Michalak M, Singh NK, Niles RM, (1996) Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. A potential pathway for cyclic AMP regulation of retinoid action. J Biol Chem 271: 15153-15159.
45. Heinlein CA, Chang C, (2001) Role of chaperones in nuclear translocation and transactivation of steroid receptors. Endocrine 14: 143-149.
46. Ding X, Goldberg MS, (2009) Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS One 4: e5949.
47. Perissi V, Rosenfeld MG, (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6: 542-554.
48. Daugaard M, Rohde M, Jaattela M, (2007) The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett 581: 3702-3710.
49. Mayer MP, (2010) Gymnastics of Molecular Chaperones. Mol Cell 39: 321-331.
50. Chang HH, Lee H, Hu MK, Tsao PN, Juan HF, et al. (2010) Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 16: 4411-4420.
51. Liao YF, Wang BJ, Hsu WM, Lee H, Liao CY, et al. (2007) Unnatural amino acid-substituted (hydroxyethyl)urea peptidomimetics inhibit gamma-secretase and promote the neuronal differentiation of neuroblastoma cells. Mol Pharmacol 71: 588-601.
52. Srinivas H, Xia D, Moore NL, Uray IP, Kim H, et al. (2006) Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. Biochem J 395: 653-662.
53. Shimada H, (2003) The International Neuroblastoma Pathology Classification. Pathologica 95: 240-241.